We read with great interest the recent report of Gwechenberger et al 1 demonstrating that cardiac myocytes in the viable border zone of myocardial infarction exhibited reperfusion-dependent expression of interleukin (IL)-6 mRNA within 1 hour in a canine model of ischemia and reperfusion. These authors point to the first direct histological demonstration of IL-6 mRNA, and they suggest the enhanced expression of IL-6 may exert primary effects on myocardial function, such as reduced contractility, positive protein balance (hypertrophy), and antiapoptosis. We agree with their hypothesis, but this is not the first demonstration of IL-6 expression in the infarcted heart in vivo.
Response
We are delighted to know of the work of Professors Kanda, Kobayashi, and Nagai. We apologize for not having found this reference; we certainly would have referred to it. The fact that this observation has been made in clinical myocardial infarction encourages us to think that our observations are clinically pertinent. We also wish to point out that similar observations were made in a rat model of myocardial infarction in an article published in this journal earlier this year, 1 in which the authors demonstrated induction in the myocyte of both interleukin (IL)-6 and IL-6 receptors utilizing immunohistochemistry with monoclonal antibodies to the proteins.
We included the suggestion that IL-6 might also induce cardiac hypertrophy in the viable border zone surrounding a myocardial infarction as a speculation. We emphasize that early induction of IL-6 in cardiac myocytes was observed only in reperfused myocardial infarctions and was not seen in the absence of reperfusion. Although the induction of IL-6 might well occur in the absence of reperfusion under certain circumstances, we were unable to demonstrate it in our model despite the fact that dogs are known to have very significant collateral circulation. Hypertrophy occurring after myocyte loss is probably primarily related to the increased hemodynamic load on the remaining viable myocardium and is not dependent on reperfusion.
A more specific protective mechanism is likely to be related to the antiapoptotic effects of IL-6 and its related cytokines. The rapid induction of these cytokines early on reperfusion allows their presence during a time period when such an action might be beneficial. The antiapoptotic effects of IL-6 -related cytokines were discussed in our article, and we continue to pursue this possibility.
